Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Galaxy Surfactants Limited (GALAXYSURF.NS)
Navi Mumbai, IN
Established in 1980 and based in Navi Mumbai, India, Galaxy Surfactants Limited operates as a manufacturer and international distributor of specialized chemical ingredients. The company primarily caters to the personal and home care industries, both within India and globally. Its extensive product range encompasses a wide variety of compounds, including fatty alcohol surfactants, ethoxylates, alkyl benzene sulphonic acids, foam and viscosity boosters, mild surfactants, and pearlizers. Additionally, they supply specialized blends, syndet and TBB bases, sun protection agents, preservatives, and a host of specialty additives such as emollients, conditioning agents, hair color protectors, scalp care solutions, and anti-microbials. These offerings are integral to products across diverse segments like skin care, hair care, sun protection, oral hygiene, baby care, and household cleaning.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.32% | -5.05% | +2.07% | -7.73% | -15.36% | -10.95% | -20.47% | -31.01% | -41.73% | +7.32% | +7.32% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 8 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+24.3% ★ Q1'26: +14.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-12.4% Q1'26: -17.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.6% Q1'26: +7.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+6.7% Q1'26: +6.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+12.7% ★ Q1'26: +12.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.50× ★ Q1'26: 0.48× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 10 Rev. Ana. 9 EPS Ana. |
Mar 2027 3 Rev. Ana. 8 EPS Ana. |
Mar 2028 8 Rev. Ana. 9 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
24.13B
est: 23.97B (+0.7%)
|
27.32B
est: 27.63B (-1.1%)
|
25.63B
est: 26.11B (-1.8%)
|
27.45B
est: 27.43B (+0.1%)
|
36.53B
est: 36.86B (-0.9%)
|
44.45B
est: 44.53B (-0.2%)
|
37.65B
est: 38.27B (-1.6%)
|
42.24B
est: 40.97B (+3.1%)
|
52.50B
51.00B – 53.58B
+28.1% YoY
|
56.36B
53.33B – 58.02B
+7.3% YoY
|
60.72B
54.28B – 64.25B
+7.7% YoY
|
64.12B
60.66B – 66.00B
+5.6% YoY
|
| EBITDA |
2.98B
est: 3.14B (-5.2%)
|
3.58B
est: 2.79B (+28.1%)
|
3.73B
est: 2.71B (+37.3%)
|
4.58B
est: 3.59B (+27.5%)
|
4.11B
est: 4.09B (+0.5%)
|
5.75B
est: 4.56B (+25.9%)
|
4.98B
est: 4.43B (+12.3%)
|
4.84B
est: 4.75B (+1.8%)
|
6.08B
5.91B – 6.21B
+27.9% YoY
|
6.53B
6.18B – 6.72B
+7.3% YoY
|
7.03B
6.29B – 7.44B
+7.7% YoY
|
7.43B
7.03B – 7.65B
+5.6% YoY
|
| EBIT |
2.49B
est: 2.58B (-3.3%)
|
3.06B
est: 2.76B (+11.0%)
|
3.10B
est: 2.87B (+8.2%)
|
3.84B
est: 3.30B (+16.3%)
|
3.40B
est: 3.76B (-9.6%)
|
4.91B
est: 4.19B (+17.1%)
|
3.98B
est: 3.56B (+11.8%)
|
3.74B
est: 3.82B (-2.0%)
|
4.88B
4.74B – 4.98B
+27.9% YoY
|
5.24B
4.96B – 5.39B
+7.3% YoY
|
5.65B
5.05B – 5.97B
+7.7% YoY
|
5.96B
5.64B – 6.14B
+5.6% YoY
|
| Net Income |
1.58B
est: 1.64B (-3.8%)
|
1.91B
est: 1.82B (+4.9%)
|
2.30B
est: 1.79B (+29.0%)
|
3.02B
est: 2.42B (+25.0%)
|
2.63B
est: 2.75B (-4.5%)
|
3.81B
est: 3.56B (+7.1%)
|
3.01B
est: 3.06B (-1.5%)
|
3.05B
est: 3.05B (+0.1%)
|
2.93B
2.78B – 3.07B
-4.0% YoY
|
3.07B
2.94B – 3.76B
+5.0% YoY
|
3.76B
3.36B – 3.98B
+22.4% YoY
|
4.36B
4.06B – 4.53B
+15.9% YoY
|
| SGA |
1.08B
est: 1.57B (-31.0%)
|
1.44B
est: 3.56B (-59.6%)
|
1.56B
est: 3.37B (-53.7%)
|
1.89B
est: 4.19B (-54.9%)
|
2.90B
est: 4.77B (-39.2%)
|
2.67B
est: 5.32B (-49.8%)
|
2.12B
est: 2.75B (-22.7%)
|
2.64B
est: 2.95B (-10.4%)
|
3.77B
3.66B – 3.85B
+27.9% YoY
|
4.05B
3.83B – 4.16B
+7.3% YoY
|
4.36B
3.90B – 4.61B
+7.7% YoY
|
4.60B
4.35B – 4.74B
+5.6% YoY
|
| EPS |
44.57
est: 46.35 (-3.8%)
|
53.87
est: 53.89 (0.0%)
|
64.99
est: 60.60 (+7.2%)
|
85.22
est: 87.80 (-2.9%)
|
74.12
est: 76.61 (-3.3%)
|
107.46
est: 112.23 (-4.2%)
|
85.03
est: 86.31 (-1.5%)
|
86.00
est: 83.88 (+2.5%)
|
82.38
78.45 – 86.46
-1.8% YoY
|
91.43
82.86 – 105.93
+11.0% YoY
|
103.63
94.64 – 112.21
+13.3% YoY
|
123.00
114.39 – 127.71
+18.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.02% | 146.5K | 0.65% |
| 2 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 668.8K | 0.06% |
| 3 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 21.7K | 0.48% |
| 4 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 49.0K | 0.26% |
| 5 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 2.42M | 0.06% |
| 6 | Vanguard ESG International Stock ETF VSGX | 0.00% | 29.1K | 0.10% |
| 7 | Vanguard Total International Stock ETF VXUS | 0.00% | 2.55M | 0.05% |
| 8 | State Street SPDR Portfolio MSCI Global Stock Market ETF SPGM | 0.00% | 3.1K | 0.09% |
| 9 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 3.9K | 0.22% |
| 10 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 11.7K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Natarajan Krishnan Kulumani | MD & Executive Director | 28M | male |
| Vaijanath S. Kulkarni | Chief Operating Officer & Executive Director | 25M | male |
| Gopalkrishnan Ramakrishnan FICWA | Strategic Advisor & Non-Executive Non-Independent Director | 11M | male |
| Abhijit Damle | Chief Financial Officer | 11M | male |
| Niranjan Arun Ketkar | Company Secretary & Compliance Officer | 3M | male |
| Kamaljit Sahota | Head of IT and Communication Management | — | male |
| Garikiparthy Sesha Samba Murty | Vice President of Conversion & Head of NPT and SHE | — | male |
| Sagar Anil Trailokya | Vice President of Quality | — | — |
| Anand Gurav | Head of Business Commercial and Operations | — | male |
| Yogesh Kalra | Vice President of Business Creation | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GALAXYSURF.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
